NCT00180219

Brief Summary

This is a single-centre, open, parallel-group study with three age groups; no study medication or intervention will be provided. This is a longitudinal follow-up of physiological parameters.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2006

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 16, 2005

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2006

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2006

Completed
Last Updated

August 25, 2016

Status Verified

August 1, 2016

First QC Date

September 14, 2005

Last Update Submit

August 24, 2016

Conditions

Pregnancy Trimester, FirstPregnancy Trimester, SecondPregnancy Trimester, Third

Keywords

G08.520.769.550.408G08.520.769.550.490G08.520.769.550.520

Study Arms (3)

1

20 to 22 years

2

30 to 32 years

3

40 to 42 years

Eligibility Criteria

Age20 Years - 42 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

three age groups

You may qualify if:

  • Pregnant women without major concomitant disease
  • Willing and able to provide informed consent
  • Age (three age groups):
  • to 22 years
  • to 32 years
  • to 42 years

You may not qualify if:

  • Non pregnant women
  • Men
  • No informed consent
  • Major concomitant disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medizinische Fakultät der Technischen Universität Dresden

Dresden, 01307, Germany

Location

MeSH Terms

Conditions

Neoplasm Metastasis

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Joachim Siegert, MD, DPharm, Phd

    Technische Universität Dresden

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 14, 2005

First Posted

September 16, 2005

Study Start

January 1, 2006

Study Completion

June 1, 2006

Last Updated

August 25, 2016

Record last verified: 2016-08

Locations

DE(1)